Protocol detail

EGFR Mutation Analysis in Ba/F3 and NIH/3T3 Cells

Protocol full text hidden due to copyright restrictions

However, the full text is available at the following link: Access Free Full Text.

Castellano G.M., Aisner J., Burley S.K., Vallat B., Yu H.A., Pine S.R, & Ganesan S. (2019). A Novel Acquired Exon 20 EGFR M766Q Mutation in Lung Adenocarcinoma Mediates Osimertinib Resistance but is Sensitive to Neratinib and Poziotinib: a Brief Report. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 14(11), 1982-1988.

Publication 2019

QuikChange XL Site-Directed Mutagenesis Kit P-ERK1/2 (#9101), P-AKT (#4060)

Agar Antibodies Assays Cells Egfr Erk1 Inhibitors Mutations Nih 3t3 Plasmids Prism Site directed mutagenesis Vinculin

Corresponding Organization : Rutgers, The State University of New Jersey

Other organizations : Memorial Sloan Kettering Cancer Center

Top 5 similar protocols

Protocol cited in 1 other protocol

Variable analysis

Dependent Variables detection not available due to copyright restrictions.
Unable to provide accurate variables.

Annotations

Annotations not available due to copyright restrictions

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!